LAUSANNE, Switzerland & BALTIMORE--(BUSINESS WIRE)--MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch of Izar ® 1, a first ...
Please provide your email address to receive an email when new articles are posted on . Patients with systemic sclerosis reported an improved ability to perform daily tasks when receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results